...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Circulation journal >Heart team approach for patients with unprotected left main coronary artery disease
【24h】

Heart team approach for patients with unprotected left main coronary artery disease

机译：心脏小组方法治疗无保护的左主冠状动脉疾病的患者

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Patients with unprotected left main coronary artery disease (LMCA) have a worse prognosis than any other form of coronary artery disease (CAD). During the past decade, the efficacy and safety of percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) for LMCA have been major topics for both interventional cardiologists and cardiac surgeons. CABG has been considered as the standard treatment modality for these patients, but as stent design, procedural technique and adjunctive medical therapy have improved, PCI has emerged as an alternative treatment option. Accordingly, PCI with stenting for LMCA was upgraded to a class Ila recommendation for properly selected patients in the 2012 guidelines of the United States.1 However, selection of optimal treatment for these patients remains controversial because of different clinical decision pathways and complicated evaluation of coronary anatomy and morbidity at the time of intervention.
机译：患有未保护的左主冠状动脉疾病（LMCA）的患者的预后比任何其他形式的冠状动脉疾病（CAD）都要差。在过去的十年中，经皮冠状动脉介入治疗（PCI）相对于LMCA冠状动脉搭桥术（CABG）的有效性和安全性一直是介入心脏病学家和心脏外科医师的主要话题。 CABG被认为是这些患者的标准治疗方式，但是随着支架设计，手术技术和辅助药物治疗的改善，PCI已成为一种替代治疗选择。因此，在美国2012年指南中，针对LMCA的支架置入术的PCI已升级为Ila类推荐标准。1但是，由于不同的临床决策途径和对冠状动脉的复杂评估，为这些患者选择最佳治疗方法仍存在争议干预时的解剖学和发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号